Brazil Approves Marijuana Medicine
0 comments
Brazil’s National Health Surveillance Agency has given approval to a cannabis-based medicine.
The approved medicine, Metavyl, is essentially one part THC to one part CBD, with slighly more THC (27mg to 25 mg per milliliter). Both the THC and CBD are derived directly from cannabis, and is not manufactures such as Marinol in the U.S. which is legal but uses synthetic, not natural THC.
According to the Agency, the medicine will be available as an oral spray to those who receive a recommendation from a physician. However, only patients who have failed to improve from traditional treatments are eligible.
In 2015 Brazil officials legalized the medical use of cannabidiol (CBD); however, the law doesn’t allow any amount of THC, which contains its own vast medical properties.